1. De Masi , J.A. Grabowski , H.G. Hansen , R.W. Innovation in the pharmaceutical industry: new estimates of R&D costs http://csdd.tufts.edu/files/uploads/Tufts_CSDD_briefing_on_RD_cost_study_-_Nov_18,_2014.pdf http://csdd.tufts.edu/files/uploads/cost_study_backgrounder.pdf 2014
2. Booth , B. A billion here, a billion there. The cost of making a drug revisited http://www.forbes.com/sites/brucebooth/2014/11/21/a-billion-here-a-billion-there-the-cost-of-making-a-drug-revisited/ 2014
3. Kielstra , P. The innovation imperative in biopharma. Reinventing biopharma strategies for an evolving marketplace http://www.economistinsights.com/sites/default/files/legacy/mgthink/downloads/The%20Innovation%20imperative%20in%20biopharma.pdf
4. Clinical biomarkers in drug discovery and development;Frank;Nat. Rev. Drug Discov.,2003